论文部分内容阅读
目的:对小儿支原体肺炎的诊治体会及临床认识进行探讨。方法:对我院2009-2010年收治确诊的58例小儿支原体肺炎患者资料进行回顾,分析和总结其临床特点。结果:5岁以上的儿童是肺炎支原体的主要感染群体,发病时出现发热、咳嗽、喘息、呼吸困难等症状,经过胸片检查大部分出现肺外脏器损害、肺部阴影。学龄前儿童为发病的主要群体,红霉素和阿奇霉素是主要的治疗药物,治愈率100%。结论:小儿支原体肺炎临床表现多种多样,病情迁延,愈后良好,容易误诊、漏诊。阿奇霉素是治疗小儿支原体肺炎的首选药物。
Objective: To investigate the diagnosis and treatment of children with mycoplasma pneumonia and clinical understanding. Methods: The data of 58 cases of mycoplasma pneumoniae pneumonia admitted in our hospital from 2009 to 2010 were retrospectively analyzed and analyzed. The clinical features were analyzed. Results: Children over the age of 5 were the main infection group of Mycoplasma pneumoniae. The symptoms of fever, cough, wheezing and dyspnea occurred on the onset of the disease. Most of the extrapulmonary organ damage and lung shadow occurred after the chest radiography. Preschool children as the main group of diseases, erythromycin and azithromycin are the main therapeutic drugs, the cure rate of 100%. Conclusion: Mycoplasma pneumonia in children with various clinical manifestations, the disease delay, the prognosis is good, easy to misdiagnosis, missed diagnosis. Azithromycin is the treatment of children with mycoplasma pneumonia drug of choice.